Skip to main content
Weight Loss
GLP-1 Receptor Agonist

Semaglutide

Ozempic® · Wegovy® · Rybelsus®

One of the most studied and effective weight loss medications available today. A once-weekly injection that works with your body's natural hunger hormones to reduce appetite and deliver significant, sustained weight loss.

What Is Semaglutide?

Semaglutide is a GLP-1 receptor agonist — a medication that mimics glucagon-like peptide-1, a hormone your gut naturally releases after eating. It signals your brain that you're full, slows the movement of food through your stomach, and reduces hunger between meals.

Originally developed to treat Type 2 diabetes (as Ozempic), it was later FDA-approved specifically for chronic weight management (as Wegovy) after clinical trials showed profound results far beyond other weight loss medications.

Clinical Trial Results

~15% Average body weight reduction (STEP 1 trial)
86% Of participants lost at least 5% of body weight
50% Of participants lost at least 15% of body weight
68 weeks Duration of STEP 1 trial (1.5 years)

Key Benefits

Up to 15% reduction in body weight

Reduces hunger and food cravings

Slows gastric emptying for longer fullness

Improves blood sugar and A1C levels

Reduces cardiovascular risk (SUSTAIN-6 trial)

Once-weekly injection — easy to maintain

FDA-approved for both diabetes (Ozempic) and weight loss (Wegovy)

Effective even without major lifestyle changes (though results improve with them)

Is Semaglutide Right for You?

Semaglutide may be appropriate if you:

  • Have a BMI ≥ 30 (obesity)
  • Have a BMI ≥ 27 with a weight-related condition (diabetes, hypertension, high cholesterol)
  • Have tried lifestyle changes without sufficient results
  • Have no contraindications to GLP-1 medications
  • Are committed to ongoing monitoring and follow-up

Who Should Not Take It

Semaglutide is not appropriate if you have:

  • Personal or family history of medullary thyroid cancer
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of pancreatitis
  • Severe gastrointestinal disease
  • Are pregnant or planning to become pregnant

What to Expect: Dosing Timeline

1
Weeks 1–4 0.25 mg weekly

Starter dose — body adjusts, most side effects peak here

2
Weeks 5–8 0.5 mg weekly

Appetite suppression begins to noticeably increase

3
Weeks 9–12 1.0 mg weekly

Full therapeutic effect, significant hunger reduction

4
Week 13+ 1.7–2.4 mg weekly

Maintenance dose based on response and tolerance

Dosing schedule is individualized based on your response and tolerance. Provider-monitored throughout.

Ready to Get Started?

Book a consultation and we'll evaluate whether semaglutide is right for you, review your health history, and get you started on a plan that works.

Book Consultation Compare All Medications